Immunoclin (Immunoclin) Short-Term Debt : $0.00 Mil (As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Short-Term Debt?

Immunoclin's Short-Term Debt for the quarter that ended in Oct. 2014 was $0.00 Mil.

Immunoclin Short-Term Debt Historical Data

The historical data trend for Immunoclin's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Short-Term Debt Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Short-Term Debt

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Short-Term Debt	Get a 7-Day Free Trial									-	-	-	-	-

Immunoclin Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Immunoclin Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Immunoclin's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines